Investigating a protein that helps maintain hearing by stabilizing hair cell structures in the inner ear
A small calcium-binding protein may be key to stabilizing the sensory hair cell stereocilia Elongation Complex
This study is looking at how a special protein helps keep the tiny hair cells in your inner ear healthy and working well, which is important for hearing, and it hopes to find new ways to help people with hearing loss.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts University Boston NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10873000 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific calcium-binding protein contributes to the stability and function of sensory hair cells in the inner ear, which are crucial for hearing. The study aims to characterize the interactions of this protein with other components of the hair bundle, particularly during its development and maintenance. By using advanced techniques, including CRISPR, the research seeks to uncover the mechanisms that lead to hearing loss when these proteins are disrupted. Patients may benefit from insights gained that could lead to new therapies for hearing impairments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic predispositions to hearing loss or those experiencing unexplained hearing impairments.
Not a fit: Patients with hearing loss due to non-genetic factors or those whose hearing loss is not related to hair cell damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help prevent or restore hearing loss caused by damage to hair cells.
How similar studies have performed: Other research has shown promising results in understanding hair cell biology and its implications for hearing restoration, suggesting that this approach has potential for success.
Where this research is happening
Boston, United States
- Tufts University Boston — Boston, United States (Active)
Researchers
- Principal investigator: Hartig, Ellen I — Tufts University Boston
- Study coordinator: Hartig, Ellen I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.